Factor viii fc fusion recomb
Products billed under this code include Eloctate.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Eloctate.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Eloctate | Bioverativ Therapeutics Inc. | 71104-0801-01 | 1 | $2.557 |
| Eloctate | Bioverativ Therapeutics Inc. | 71104-0802-01 | 1 | $2.557 |
| Eloctate | Bioverativ Therapeutics Inc. | 71104-0803-01 | 1 | $2.557 |
| Eloctate | Bioverativ Therapeutics Inc. | 71104-0804-01 | 1 | $2.557 |
| Eloctate | Bioverativ Therapeutics Inc. | 71104-0805-01 | 1 | $2.557 |
| Eloctate | Bioverativ Therapeutics Inc. | 71104-0806-01 | 1 | $2.557 |
| Eloctate | Bioverativ Therapeutics Inc. | 71104-0807-01 | 1 | $2.557 |
| Eloctate | Bioverativ Therapeutics Inc. | 71104-0808-01 | 1 | $2.557 |
| Eloctate | Bioverativ Therapeutics Inc. | 71104-0809-01 | 1 | $2.557 |
| Eloctate | Bioverativ Therapeutics Inc. | 71104-0810-01 | 1 | $2.557 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.557 | −$0.021 | 1 IU | Factor viii fc fusion recomb | v1, posted September 17, 2026 |
| 3Q26 | $2.578 | +$0.116 | 1 IU | Factor viii fc fusion recomb | v1, posted September 15, 2026 |
| 2Q26 | $2.462 | −$0.007 | 1 IU | Factor viii fc fusion recomb | v1, posted September 15, 2026 |
| 1Q26 | $2.469 | +$0.043 | 1 IU | Factor viii fc fusion recomb | v1, posted September 15, 2026 |
| 4Q25 | $2.426 | +$0.004 | 1 IU | Factor viii fc fusion recomb | v1, posted September 8, 2026 |
| 3Q25 | $2.422 | +$0.102 | 1 IU | Factor viii fc fusion recomb | v1, posted March 10, 2026 |
| 2Q25 | $2.32 | −$0.018 | 1 IU | Factor viii fc fusion recomb | v1, posted March 10, 2026 |
| 1Q25 | $2.338 | −$0.006 | 1 IU | Factor viii fc fusion recomb | v1, posted December 19, 2025 |
| 4Q24 | $2.344 | +$0.046 | 1 IU | Factor viii fc fusion recomb | v1, posted June 11, 2025 |
| 3Q24 | $2.298 | +$0.092 | 1 IU | Factor viii fc fusion recomb | v1, posted June 11, 2025 |
| 2Q24 | $2.206 | +$0.018 | 1 IU | Factor viii fc fusion recomb | v1, posted March 11, 2025 |
| 1Q24 | $2.188 | +$0.008 | 1 IU | Factor viii fc fusion recomb | v1, posted December 19, 2024 |
| 4Q23 | $2.18 | +$0.007 | 1 IU | Factor viii fc fusion recomb | v1, posted October 10, 2024 |
| 3Q23 | $2.173 | −$0.003 | 1 IU | Factor viii fc fusion recomb | v1, posted June 5, 2024 |
| 2Q23 | $2.176 | +$0.037 | 1 IU | Factor viii fc fusion recomb | v1, posted February 23, 2024 |
| 1Q23 | $2.139 | −$0.016 | 1 IU | Factor viii fc fusion recomb | v1, posted December 6, 2023 |
| 4Q22 | $2.155 | −$0.013 | 1 IU | Factor viii fc fusion recomb | v1, posted June 22, 2023 |
| 3Q22 | $2.168 | +$0.041 | 1 IU | Factor viii fc fusion recomb | v1, posted June 9, 2023 |
| 2Q22 | $2.127 | +$0.01 | 1 IU | Factor viii fc fusion recomb | v1, posted December 14, 2022 |
| 1Q22 | $2.117 | −$0.034 | 1 IU | Factor viii fc fusion recomb | v1, posted June 8, 2022 |
| 4Q21 | $2.151 | +$0.033 | 1 IU | Factor viii fc fusion recomb | v1, posted June 2, 2022 |
| 3Q21 | $2.118 | −$0.062 | 1 IU | Factor viii fc fusion recomb | v1, posted June 2, 2022 |
| 2Q21 | $2.18 | +$0.007 | 1 IU | Factor viii fc fusion recomb | v1, posted March 1, 2022 |
| 1Q21 | $2.173 | – | 1 IU | Factor viii fc fusion recomb | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.